PHVS
PHVS
NASDAQ · Pharmaceuticals

Pharvaris Nv

$29.44
-1.57 (-5.06%)
As of May 9, 1:33 AM ET ·
Financial Highlights (FY 2025)
Revenue
601.07M
Net Income
107.25M
Gross Margin
53.4%
Profit Margin
17.8%
Rev Growth
+10.0%
D/E Ratio
0.21
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 53.4% 53.4% 53.4%
Operating Margin 22.1% 20.6% 22.5%
Profit Margin 17.8% 19.4% 17.5%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 601.07M 622.81M 541.11M
Gross Profit 320.95M 332.55M 288.93M
Operating Income 133.12M 128.16M 121.98M
Net Income 107.25M 120.49M 94.92M
Gross Margin 53.4% 53.4% 53.4%
Operating Margin 22.1% 20.6% 22.5%
Profit Margin 17.8% 19.4% 17.5%
Rev Growth +10.0% +14.9% +24.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 233.84M 201.55M 201.04M
Total Equity 1.12B 985.27M 1.01B
D/E Ratio 0.21 0.20 0.20
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 198.86M 206.18M 175.68M
Free Cash Flow 71.76M 51.92M 65.95M